In this episode, Keith Channon discusses the advancements in cardiac diagnostics through Caristo Diagnostics and their innovative product, Carry Heart. The conversation delves into the persistent issue of heart attacks, the limitations of current diagnostic methods, and how Carry Heart utilizes advanced imaging technology to assess inflammation in coronary arteries, providing a more accurate risk assessment for patients. The discussion also covers the clinical implications of this technology and actionable steps for patients to reduce their risk of cardiovascular events. In this conversation, Keith Channon discusses the evolving landscape of cardiovascular medicine, focusing on the optimization of drug dosing, the integration of AI in risk prediction, and the importance of targeted therapies. He highlights the potential of new technologies to enhance patient outcomes and the need for regulatory approval to facilitate wider clinical use. The discussion also touches on the significance of understanding inflammation in cardiovascular disease and the future applications of these advancements beyond cardiology.